NCT04364607View on ClinicalTrials.gov

IM Neostigmine for Accelerating Bladder Emptying After CS by Spinal Anesthesia

PHASE4CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

August 5, 2020

Primary Completion Date

October 26, 2021

Study Completion Date

October 26, 2021

Conditions
Cesarean Section Complications
Interventions
DRUG

Neostigmine

Participants will receive 0.5 mg IM neostigmine

DRUG

NaCl 0.9%

Participants will receive IM NaCl 0.9% as a placebo

Trial Locations (1)

35111

Mansoura University Hospital, Al Mansurah

All Listed Sponsors
lead

Mansoura University

OTHER

NCT04364607 - IM Neostigmine for Accelerating Bladder Emptying After CS by Spinal Anesthesia | Biotech Hunter | Biotech Hunter